Non-Emergency Medical Transportation Market, by Service Type (Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, Transportation Management and Optimization), by Applications (Dialysis, Routine Doctor Visits, Mental Health-Related Appointments, Medical Specialist Visits, Rehabilitation, Testing/Screening-Related Appointments, Chemotherapy, Others), by Age Groups (Below 20 years, 20 to 60 years, 60+ years) by Region (United States, Canada, Mexico, Rest of North America, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) — Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019–2027
Market Overview/Industry Trends
The healthcare industry is said to be evergreen in the sense that the market is expected to see a significant growth each year. Government agencies all over the globe spend a significant portion of their revenue on healthcare. Emergency healthcare facilities are deeply organized in developed countries such as the U.S., Canada, Germany, Sweden, Australia, the UK, etc. The U.S., for example, spent US$ 3.5 trillion on healthcare in 2017, according to the U.S. Centers for Medicare & Medicaid Services (CMS. The fact that the per capita spending is around US$ 10,739 is indeed staggering. Hospitals have a well-established emergency health transportation service. Non-emergency medical transportation (NEMT), however, is an emerging market with high potential. Non-emergency health transportation can be defined as a service offered to the general populace that requires medical care, but their situation isn’t critical. An emergency, according to the CMS, is an event that endangers the life of an individual without adequate care. Examples of these include cardiac arrest, vehicle accident, internal or external bleeding, brain trauma, etc. Non-emergency medical transportation covers non-lethal events such as medical appointments and regular check-ups. Usually, the NEMT service providers are adopting a pick-up and drop business model. The benefactors of NEMT services include geriatric population, citizens without a driver’s license, citizens who do not own a vehicle and physically challenged population, amongst others. Rise in individuals aged 65 or above in countries such as Japan and Italy is one of the major reasons for the growth of the global non-emergency medical transportation market. Interestingly, the medicaid program in the U.S. covers NEMT. Medicaid holders are eligible for two-way transportation. A well-structured NEMT will help citizens over the transportation barriers, decrease in-patient spending and ensure that regular appointments aren’t missed.
In terms of revenue, the global non-emergency medical transportation market was estimated to be US$ 8,172.31 Mn in 2018 and is expected to reach US$ 12,677.58 Mn by 2027 growing at a CAGR of 4.9% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which has been further bifurcated into countries.
Non-Emergency Medical Transportation Market Revenue & Forecast, (US$ Million), 2015–2027
Services Outlook:
The services provided by the NEMT companies can be divided into different types. They are private pay patient transportation, insurance-backed patient transportation, courier services and transportation management and optimization. Private pay patient transportation and insurance backed patient transportation can be further sub-divided into standard services and special assistance services. Private pay patient transportation service companies provide NEMT services to any citizen, regardless of their insurance coverage. It can be considered as a specialized cab service for those that require non-emergency care. The patients can book a NEMT service by logging into a mobile app or via making a phone call. In countries such as the U.S. and the UK, digitization has ensured that the vast majority of the population have accessibility to the internet, which further ensures hassle-free bookings. The consumers can also opt for a NEMT service as part of their insurance plan. This comes under the insurance backed patient transportation service. The burden on the end-users is highly reduced in this case. However, people prefer to opt for private pay patient transportation predominantly due to the non-periodicity in visits. As a result of this, this segment accounted for the highest market share in the global non-emergency medical transportation market, with total revenue of US$ 4169.16 in 2018. Due to the increasing penetration of NEMT service in rural and suburban areas and the higher cost of insurance plans, private pay patient transportation is expected to grow the maximum during the forecast years, at a CAGR of 5.5%.
Age Group Outlook:
Based on the end-users of non-emergency medical transportation services, the market can be divided into three age groups. They are: - below 20 years, 20-60 years and above 60 years. Routine check-ups and doctor visits may become a part of an individual’s schedule when they’ve crossed the first half of their lifecycle. The maximum revenue of the NEMT companies came from the 60 plus years’ age group, with a total figure of US$ 6267.25. This accounts for about 76% of the total market share. The highest growth rate is also estimated to be shown by this age group, with an expected CAGR of 5.2%. The second-highest growth rate is anticipated from the 20-60 years’ category in the non-emergency medical transportation market.
Application Outlook:
The end-users opt for NEMT services for numerous purposes. Based on the application, the global non-emergency medical transportation market can be divided into dialysis, routine doctor visits, mental health-related appointments, medical specialist visits, rehabilitation, testing/screening-related appointments and chemotherapy, amongst others. For instance, dialysis is provided to those patients that have acute kidney failure. The removal of water, solutes and other residues is carried out during dialysis. These patients need additional care during hospital visits and for other commutes, which is one of the major reasons responsible for the major market share of dialysis in the global non-emergency medical transportation market in 2018.
Moreover, patients with mental health-related issues aren’t legally allowed to use their vehicle for transportation. Physiotherapy needs to be performed for those who have experienced physical injuries. People also use NEMT services for routine doctor visits and this application holds the second position in terms of market revenue in 2018, with a total share of 25.78% in non-emergency medical transportation market. However, testing/screening-related appointments segment is expected to grow the highest during the forecast years at a CAGR of 5.6%.
Region Outlook:
As far as the regions are concerned, North America accounted for the lion’s share holding 64.06% of the market in 2018. The presence of several NEMT providers in this region is a major factor for this phenomenon. Companies such as ABC Non-Emergency Medical Transportation, LLC provide NEMT services in the U.S. The incorporation of NEMT services as part of medicaid provides additional revenue for the market players. Highly-advanced transportation systems with modern facilities are available for routine doctor visits and specialized purposes. The APAC region is catching up with their western counterparts at a faster pace. The region is expected to show the highest growth during the forecast years, with a CAGR of 7.9%. This can be attributed to the increasing digitization in this region coupled with growth of ride-sharing platforms such as Uber, aiding in the non-emergency medical transportation market growth.
Competitive Landscape
The report provides both qualitative and quantitative research of non-emergency medical transportation market as well as provides comprehensive insights and development methods adopted by the prominent market players. Some of the key market participants in the non-emergency medical transportation market are ABC Non-Emergency Medical Transportation, LLC, Acadian Ambulance Service, Access2Care, ALC., Ecolane, ERS Transition Ltd, Express Medical Transporters, IU Group, LogistiCare Solutions, LLC, and London Medical Transportation Systems, Lyft, Inc., Uber Technologies Inc., amongst others. Several companies are increasingly focusing on patients that require regular health check-ups. Subscription options are provided at discounted prices. Round the clock care enables the patients to avail non-emergency medical transportation facilities with ease. Companies are increasingly focusing on forming strategic partnerships with healthcare providers in order to help their patients avail non-emergency medical transportation services with ease. Lyft, Inc., for example, has struck a transportation deal with Sacramento-headquartered non-profit health system Sutter Health. The former also has entered into a formal partnership with CommonSpirit Health, which is among the largest non-profit health system in the U.S. Uber Technologies Inc. that already has more than 1000 partnerships in the U.S., with leading providers such as BayCare Health System and Cleveland Clinic.
Global Non-Emergency Medical Transportation Market:
- By Service Type
- Private Pay Patient Transportation
- Insurance Backed Patient Transportation
- Courier Services
- Transportation Management and Optimization
- By Application
- Dialysis
- Routine doctor visits
- Mental health-related appointments
- Medical specialist visits
- Rehabilitation
- Testing/screening-related appointments
- Chemotherapy
- Others
- By Age Groups
- Below 20 years
- 20 to 60 years
- 60+ years
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Non-Emergency Health Transportation
Market
6. Market Synopsis:
Non-Emergency Health Transportation Market
7. Non-Emergency Health Transportation Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Non-Emergency Health Transportation Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Non-Emergency Health Transportation Market
7.6. Porter’s
Five Force Analysis
8. Global Non-Emergency Health Transportation Market Analysis
and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Non-Emergency Health Transportation Market Revenue (US$ Mn)
8.2. Global
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By Service
Type
8.2.1. Private
Pay Patient Transportation (Definition, Market Estimation and Penetration, 2013
– 2018, Market Estimation (2013 – 2018), Market Forecast (2019 – 2027),
Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America,
Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on
Standard, Special Assistance)
8.2.1.1. Standard
8.2.1.2. Special
Assistance
8.2.2. Insurance
Backed Patient Transportation (Definition, Market Estimation and Penetration,
2013 – 2018, Market Estimation (2013 – 2018), Market Forecast (2019 – 2027),
Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America,
Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on
Standard, Special Assistance)
8.2.2.1. Standard
8.2.2.2. Special
Assistance
8.2.3. Courier
Services
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2013 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2013 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2013 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2013 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2013 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2013 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.2.4. Transportation
Management and Optimization
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2013 – 2018
8.2.4.3. Market
Forecast, 2019 – 2027
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2013 – 2018
8.2.4.5.1.2. Market
Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2013 – 2018
8.2.4.5.2.2. Market
Forecast, 2019 – 2027
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2013 – 2018
8.2.4.5.3.2. Market
Forecast, 2019 – 2027
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2013 – 2018
8.2.4.5.4.2. Market
Forecast, 2019 – 2027
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2013 – 2018
8.2.4.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Service Type
9. Global Non-Emergency Health Transportation Market Analysis
and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
9.2.1. Dialysis
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2013 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2013 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2013 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2013 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2013 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2013 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. Routine
Doctor Visits
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2013 – 2018
9.2.2.3. Market
Forecast, 2019 – 2027
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2013 – 2018
9.2.2.5.1.2. Market
Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2013 – 2018
9.2.2.5.2.2. Market
Forecast, 2019 – 2027
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2013 – 2018
9.2.2.5.3.2. Market
Forecast, 2019 – 2027
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2013 – 2018
9.2.2.5.4.2. Market
Forecast, 2019 – 2027
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2013 – 2018
9.2.2.5.5.2. Market
Forecast, 2019 – 2027
9.2.3. Mental
Health-Related Appointments
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2013 – 2018
9.2.3.3. Market
Forecast, 2019 – 2027
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market
Estimation, 2013 – 2018
9.2.3.5.1.2. Market
Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2013 – 2018
9.2.3.5.2.2. Market
Forecast, 2019 – 2027
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market
Estimation, 2013 – 2018
9.2.3.5.3.2. Market
Forecast, 2019 – 2027
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market
Estimation, 2013 – 2018
9.2.3.5.4.2. Market
Forecast, 2019 – 2027
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market
Estimation, 2013 – 2018
9.2.3.5.5.2. Market
Forecast, 2019 – 2027
9.2.4. Medical Specialist
Visits
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2013 – 2018
9.2.4.3. Market
Forecast, 2019 – 2027
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market
Estimation, 2013 – 2018
9.2.4.5.1.2. Market
Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2013 – 2018
9.2.4.5.2.2. Market
Forecast, 2019 – 2027
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market
Estimation, 2013 – 2018
9.2.4.5.3.2. Market
Forecast, 2019 – 2027
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market
Estimation, 2013 – 2018
9.2.4.5.4.2. Market
Forecast, 2019 – 2027
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market
Estimation, 2013 – 2018
9.2.4.5.5.2. Market
Forecast, 2019 – 2027
9.2.5. Rehabilitation
9.2.5.1. Definition
9.2.5.2. Market
Estimation and Penetration, 2013 – 2018
9.2.5.3. Market
Forecast, 2019 – 2027
9.2.5.4. Compound
Annual Growth Rate (CAGR)
9.2.5.5. Regional
Bifurcation
9.2.5.5.1. North
America
9.2.5.5.1.1. Market
Estimation, 2013 – 2018
9.2.5.5.1.2. Market
Forecast, 2019 – 2027
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2013 – 2018
9.2.5.5.2.2. Market
Forecast, 2019 – 2027
9.2.5.5.3. Asia
Pacific
9.2.5.5.3.1. Market
Estimation, 2013 – 2018
9.2.5.5.3.2. Market
Forecast, 2019 – 2027
9.2.5.5.4. Middle
East and Africa
9.2.5.5.4.1. Market
Estimation, 2013 – 2018
9.2.5.5.4.2. Market
Forecast, 2019 – 2027
9.2.5.5.5. Latin
America
9.2.5.5.5.1. Market
Estimation, 2013 – 2018
9.2.5.5.5.2. Market
Forecast, 2019 – 2027
9.2.6. Testing/Screening-Related
Appointments
9.2.6.1. Definition
9.2.6.2. Market
Estimation and Penetration, 2013 – 2018
9.2.6.3. Market
Forecast, 2019 – 2027
9.2.6.4. Compound
Annual Growth Rate (CAGR)
9.2.6.5. Regional
Bifurcation
9.2.6.5.1. North
America
9.2.6.5.1.1. Market
Estimation, 2013 – 2018
9.2.6.5.1.2. Market
Forecast, 2019 – 2027
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2013 – 2018
9.2.6.5.2.2. Market
Forecast, 2019 – 2027
9.2.6.5.3. Asia
Pacific
9.2.6.5.3.1. Market
Estimation, 2013 – 2018
9.2.6.5.3.2. Market
Forecast, 2019 – 2027
9.2.6.5.4. Middle
East and Africa
9.2.6.5.4.1. Market
Estimation, 2013 – 2018
9.2.6.5.4.2. Market
Forecast, 2019 – 2027
9.2.6.5.5. Latin
America
9.2.6.5.5.1. Market
Estimation, 2013 – 2018
9.2.6.5.5.2. Market
Forecast, 2019 – 2027
9.2.7. Chemotherapy
9.2.7.1. Definition
9.2.7.2. Market
Estimation and Penetration, 2013 – 2018
9.2.7.3. Market
Forecast, 2019 – 2027
9.2.7.4. Compound
Annual Growth Rate (CAGR)
9.2.7.5. Regional
Bifurcation
9.2.7.5.1. North
America
9.2.7.5.1.1. Market
Estimation, 2013 – 2018
9.2.7.5.1.2. Market
Forecast, 2019 – 2027
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2013 – 2018
9.2.7.5.2.2. Market
Forecast, 2019 – 2027
9.2.7.5.3. Asia
Pacific
9.2.7.5.3.1. Market
Estimation, 2013 – 2018
9.2.7.5.3.2. Market
Forecast, 2019 – 2027
9.2.7.5.4. Middle
East and Africa
9.2.7.5.4.1. Market
Estimation, 2013 – 2018
9.2.7.5.4.2. Market
Forecast, 2019 – 2027
9.2.7.5.5. Latin
America
9.2.7.5.5.1. Market
Estimation, 2013 – 2018
9.2.7.5.5.2. Market
Forecast, 2019 – 2027
9.2.8. Others
9.2.8.1. Definition
9.2.8.2. Market
Estimation and Penetration, 2013 – 2018
9.2.8.3. Market
Forecast, 2019 – 2027
9.2.8.4. Compound
Annual Growth Rate (CAGR)
9.2.8.5. Regional
Bifurcation
9.2.8.5.1. North
America
9.2.8.5.1.1. Market
Estimation, 2013 – 2018
9.2.8.5.1.2. Market
Forecast, 2019 – 2027
9.2.8.5.2. Europe
9.2.8.5.2.1. Market
Estimation, 2013 – 2018
9.2.8.5.2.2. Market
Forecast, 2019 – 2027
9.2.8.5.3. Asia
Pacific
9.2.8.5.3.1. Market
Estimation, 2013 – 2018
9.2.8.5.3.2. Market
Forecast, 2019 – 2027
9.2.8.5.4. Middle
East and Africa
9.2.8.5.4.1. Market
Estimation, 2013 – 2018
9.2.8.5.4.2. Market
Forecast, 2019 – 2027
9.2.8.5.5. Latin
America
9.2.8.5.5.1. Market
Estimation, 2013 – 2018
9.2.8.5.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By Application
10. Global Non-Emergency Health Transportation Market Analysis
and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
10.2.1. Below
20 years
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2013 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2013 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2013 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2013 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2013 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2013 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. 20 to
60 years
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2013 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2013 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2013 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2013 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2013 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2013 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.2.3. 60+
years
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2013 – 2018
10.2.3.3. Market
Forecast, 2019 – 2027
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2013 – 2018
10.2.3.5.1.2. Market
Forecast, 2019 – 2027
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2013 – 2018
10.2.3.5.2.2. Market
Forecast, 2019 – 2027
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2013 – 2018
10.2.3.5.3.2. Market
Forecast, 2019 – 2027
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2013 – 2018
10.2.3.5.4.2. Market
Forecast, 2019 – 2027
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2013 – 2018
10.2.3.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By Age
Groups
11. North America Non-Emergency Health Transportation Market
Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. North
America Non-Emergency Health Transportation Market Revenue (US$ Mn)
11.2. North
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
11.2.1. Private
Pay Patient Transportation
11.2.1.1. Standard
11.2.1.2. Special
Assistance
11.2.2. Insurance
Backed Patient Transportation
11.2.2.1. Standard
11.2.2.2. Special
Assistance
11.2.3. Courier
Services
11.2.4. Transportation
Management and Optimization
11.3. North
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
11.3.1. Dialysis
11.3.2. Routine
Doctor Visits
11.3.3. Mental
Health-Related Appointments
11.3.4. Medical
Specialist Visits
11.3.5. Rehabilitation
11.3.6. Testing/Screening-Related
Appointments
11.3.7. Chemotherapy
11.3.8. Others
11.4. North
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
11.4.1. Below
20 years
11.4.2. 20 to
60 years
11.4.3. 60+
years
11.5. North
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
11.5.1.1.1. Private
Pay Patient Transportation
11.5.1.1.1.1. Standard
11.5.1.1.1.2. Special
Assistance
11.5.1.1.2. Insurance
Backed Patient Transportation
11.5.1.1.2.1. Standard
11.5.1.1.2.2. Special
Assistance
11.5.1.1.3. Courier
Services
11.5.1.1.4. Transportation
Management and Optimization
11.5.1.2. U.S
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.1.2.1. Dialysis
11.5.1.2.2. Routine
Doctor Visits
11.5.1.2.3. Mental
Health-Related Appointments
11.5.1.2.4. Medical
Specialist Visits
11.5.1.2.5. Rehabilitation
11.5.1.2.6. Testing/Screening-Related
Appointments
11.5.1.2.7. Chemotherapy
11.5.1.2.8. Others
11.5.1.3. U.S
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
11.5.1.3.1. Below
20 years
11.5.1.3.2. 20
to 60 years
11.5.1.3.3. 60+
years
11.5.2. Canada
11.5.2.1. Canada
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
11.5.2.1.1. Private
Pay Patient Transportation
11.5.2.1.1.1. Standard
11.5.2.1.1.2. Special
Assistance
11.5.2.1.2. Insurance
Backed Patient Transportation
11.5.2.1.2.1. Standard
11.5.2.1.2.2. Special
Assistance
11.5.2.1.3. Courier
Services
11.5.2.1.4. Transportation
Management and Optimization
11.5.2.2. Canada
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.2.2.1. Dialysis
11.5.2.2.2. Routine
Doctor Visits
11.5.2.2.3. Mental
Health-Related Appointments
11.5.2.2.4. Medical
Specialist Visits
11.5.2.2.5. Rehabilitation
11.5.2.2.6. Testing/Screening-Related
Appointments
11.5.2.2.7. Chemotherapy
11.5.2.2.8. Others
11.5.2.3. Canada
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
11.5.2.3.1. Below
20 years
11.5.2.3.2. 20
to 60 years
11.5.2.3.3. 60+
years
11.5.3. Mexico
11.5.3.1. Mexico
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
11.5.3.1.1. Private
Pay Patient Transportation
11.5.3.1.1.1. Standard
11.5.3.1.1.2. Special
Assistance
11.5.3.1.2. Insurance
Backed Patient Transportation
11.5.3.1.2.1. Standard
11.5.3.1.2.2. Special
Assistance
11.5.3.1.3. Courier
Services
11.5.3.1.4. Transportation
Management and Optimization
11.5.3.2. Mexico
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.3.2.1. Dialysis
11.5.3.2.2. Routine
Doctor Visits
11.5.3.2.3. Mental
Health-Related Appointments
11.5.3.2.4. Medical
Specialist Visits
11.5.3.2.5. Rehabilitation
11.5.3.2.6. Testing/Screening-Related
Appointments
11.5.3.2.7. Chemotherapy
11.5.3.2.8. Others
11.5.3.3. Mexico
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
11.5.3.3.1. Below
20 years
11.5.3.3.2. 20
to 60 years
11.5.3.3.3. 60+
years
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Service Type
11.5.4.1.1. Private
Pay Patient Transportation
11.5.4.1.1.1. Standard
11.5.4.1.1.2. Special
Assistance
11.5.4.1.2. Insurance
Backed Patient Transportation
11.5.4.1.2.1. Standard
11.5.4.1.2.2. Special
Assistance
11.5.4.1.3. Courier
Services
11.5.4.1.4. Transportation
Management and Optimization
11.5.4.2. Rest
of North America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Application
11.5.4.2.1. Dialysis
11.5.4.2.2. Routine
Doctor Visits
11.5.4.2.3. Mental
Health-Related Appointments
11.5.4.2.4. Medical
Specialist Visits
11.5.4.2.5. Rehabilitation
11.5.4.2.6. Testing/Screening-Related
Appointments
11.5.4.2.7. Chemotherapy
11.5.4.2.8. Others
11.5.4.3. Rest
of North America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Age Groups
11.5.4.3.1. Below
20 years
11.5.4.3.2. 20
to 60 years
11.5.4.3.3. 60+
years
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Service Type
11.6.3. By
Application
11.6.4. By Age
Groups
12. Europe Non-Emergency Health Transportation Market Analysis
and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Europe
Non-Emergency Health Transportation Market Revenue (US$ Mn)
12.2. Europe
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
12.2.1. Private
Pay Patient Transportation
12.2.1.1. Standard
12.2.1.2. Special
Assistance
12.2.2. Insurance
Backed Patient Transportation
12.2.2.1. Standard
12.2.2.2. Special
Assistance
12.2.3. Courier
Services
12.2.4. Transportation
Management and Optimization
12.3. Europe
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
12.3.1. Dialysis
12.3.2. Routine
Doctor Visits
12.3.3. Mental
Health-Related Appointments
12.3.4. Medical
Specialist Visits
12.3.5. Rehabilitation
12.3.6. Testing/Screening-Related
Appointments
12.3.7. Chemotherapy
12.3.8. Others
12.4. Europe
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
12.4.1. Below
20 years
12.4.2. 20 to
60 years
12.4.3. 60+
years
12.5. Europe
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.1. France
12.5.1.1. France
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
12.5.1.1.1. Private
Pay Patient Transportation
12.5.1.1.1.1. Standard
12.5.1.1.1.2. Special
Assistance
12.5.1.1.2. Insurance
Backed Patient Transportation
12.5.1.1.2.1. Standard
12.5.1.1.2.2. Special
Assistance
12.5.1.1.3. Courier
Services
12.5.1.1.4. Transportation
Management and Optimization
12.5.1.2. France
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.1.2.1. Dialysis
12.5.1.2.2. Routine
Doctor Visits
12.5.1.2.3. Mental
Health-Related Appointments
12.5.1.2.4. Medical
Specialist Visits
12.5.1.2.5. Rehabilitation
12.5.1.2.6. Testing/Screening-Related
Appointments
12.5.1.2.7. Chemotherapy
12.5.1.2.8. Others
12.5.1.3. France
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
12.5.1.3.1. Below
20 years
12.5.1.3.2. 20 to
60 years
12.5.1.3.3. 60+
years
12.5.2. The UK
12.5.2.1. The
UK Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Service Type
12.5.2.1.1. Private
Pay Patient Transportation
12.5.2.1.1.1. Standard
12.5.2.1.1.2. Special
Assistance
12.5.2.1.2. Insurance
Backed Patient Transportation
12.5.2.1.2.1. Standard
12.5.2.1.2.2. Special
Assistance
12.5.2.1.3. Courier
Services
12.5.2.1.4. Transportation
Management and Optimization
12.5.2.2. The
UK Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.2.2.1. Dialysis
12.5.2.2.2. Routine
Doctor Visits
12.5.2.2.3. Mental
Health-Related Appointments
12.5.2.2.4. Medical
Specialist Visits
12.5.2.2.5. Rehabilitation
12.5.2.2.6. Testing/Screening-Related
Appointments
12.5.2.2.7. Chemotherapy
12.5.2.2.8. Others
12.5.2.3. The
UK Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Age Groups
12.5.2.3.1. Below
20 years
12.5.2.3.2. 20
to 60 years
12.5.2.3.3. 60+
years
12.5.3. Spain
12.5.3.1. Spain
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
12.5.3.1.1. Private
Pay Patient Transportation
12.5.3.1.1.1. Standard
12.5.3.1.1.2. Special
Assistance
12.5.3.1.2. Insurance
Backed Patient Transportation
12.5.3.1.2.1. Standard
12.5.3.1.2.2. Special
Assistance
12.5.3.1.3. Courier
Services
12.5.3.1.4. Transportation
Management and Optimization
12.5.3.2. Spain
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.3.2.1. Dialysis
12.5.3.2.2. Routine
Doctor Visits
12.5.3.2.3. Mental
Health-Related Appointments
12.5.3.2.4. Medical
Specialist Visits
12.5.3.2.5. Rehabilitation
12.5.3.2.6. Testing/Screening-Related
Appointments
12.5.3.2.7. Chemotherapy
12.5.3.2.8. Others
12.5.3.3. Spain
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
12.5.3.3.1. Below
20 years
12.5.3.3.2. 20
to 60 years
12.5.3.3.3. 60+
years
12.5.4. Germany
12.5.4.1. Germany
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
12.5.4.1.1. Private
Pay Patient Transportation
12.5.4.1.1.1. Standard
12.5.4.1.1.2. Special
Assistance
12.5.4.1.2. Insurance
Backed Patient Transportation
12.5.4.1.2.1. Standard
12.5.4.1.2.2. Special
Assistance
12.5.4.1.3. Courier
Services
12.5.4.1.4. Transportation
Management and Optimization
12.5.4.2. Germany
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.4.2.1. Dialysis
12.5.4.2.2. Routine
Doctor Visits
12.5.4.2.3. Mental
Health-Related Appointments
12.5.4.2.4. Medical
Specialist Visits
12.5.4.2.5. Rehabilitation
12.5.4.2.6. Testing/Screening-Related
Appointments
12.5.4.2.7. Chemotherapy
12.5.4.2.8. Others
12.5.4.3. Germany
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
12.5.4.3.1. Below
20 years
12.5.4.3.2. 20
to 60 years
12.5.4.3.3. 60+
years
12.5.5. Italy
12.5.5.1. Italy
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
12.5.5.1.1. Private
Pay Patient Transportation
12.5.5.1.1.1. Standard
12.5.5.1.1.2. Special
Assistance
12.5.5.1.2. Insurance
Backed Patient Transportation
12.5.5.1.2.1. Standard
12.5.5.1.2.2. Special
Assistance
12.5.5.1.3. Courier
Services
12.5.5.1.4. Transportation
Management and Optimization
12.5.5.2. Italy
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
12.5.5.2.1. Dialysis
12.5.5.2.2. Routine
Doctor Visits
12.5.5.2.3. Mental
Health-Related Appointments
12.5.5.2.4. Medical
Specialist Visits
12.5.5.2.5. Rehabilitation
12.5.5.2.6. Testing/Screening-Related
Appointments
12.5.5.2.7. Chemotherapy
12.5.5.2.8. Others
12.5.5.3. Italy
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
12.5.5.3.1. Below
20 years
12.5.5.3.2. 20
to 60 years
12.5.5.3.3. 60+
years
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
12.5.6.1.1. Private
Pay Patient Transportation
12.5.6.1.1.1. Standard
12.5.6.1.1.2. Special
Assistance
12.5.6.1.2. Insurance
Backed Patient Transportation
12.5.6.1.2.1. Standard
12.5.6.1.2.2. Special
Assistance
12.5.6.1.3. Courier
Services
12.5.6.1.4. Transportation
Management and Optimization
12.5.6.2. Nordic
Countries Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.6.2.1. Dialysis
12.5.6.2.2. Routine
Doctor Visits
12.5.6.2.3. Mental
Health-Related Appointments
12.5.6.2.4. Medical
Specialist Visits
12.5.6.2.5. Rehabilitation
12.5.6.2.6. Testing/Screening-Related
Appointments
12.5.6.2.7. Chemotherapy
12.5.6.2.8. Others
12.5.6.3. Nordic
Countries Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
12.5.6.3.1. Below
20 years
12.5.6.3.2. 20
to 60 years
12.5.6.3.3. 60+
years
12.5.6.4. Nordic
Countries Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
12.5.7.1.1. Private
Pay Patient Transportation
12.5.7.1.1.1. Standard
12.5.7.1.1.2. Special
Assistance
12.5.7.1.2. Insurance
Backed Patient Transportation
12.5.7.1.2.1. Standard
12.5.7.1.2.2. Special
Assistance
12.5.7.1.3. Courier
Services
12.5.7.1.4. Transportation
Management and Optimization
12.5.7.2. Benelux
Union Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.7.2.1. Dialysis
12.5.7.2.2. Routine
Doctor Visits
12.5.7.2.3. Mental
Health-Related Appointments
12.5.7.2.4. Medical
Specialist Visits
12.5.7.2.5. Rehabilitation
12.5.7.2.6. Testing/Screening-Related
Appointments
12.5.7.2.7. Chemotherapy
12.5.7.2.8. Others
12.5.7.3. Benelux
Union Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
12.5.7.3.1. Below
20 years
12.5.7.3.2. 20
to 60 years
12.5.7.3.3. 60+
years
12.5.7.4. Benelux
Union Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
12.5.8.1.1. Private
Pay Patient Transportation
12.5.8.1.1.1. Standard
12.5.8.1.1.2. Special
Assistance
12.5.8.1.2. Insurance
Backed Patient Transportation
12.5.8.1.2.1. Standard
12.5.8.1.2.2. Special
Assistance
12.5.8.1.3. Courier
Services
12.5.8.1.4. Transportation
Management and Optimization
12.5.8.2. Rest
of Europe Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.8.2.1. Dialysis
12.5.8.2.2. Routine
Doctor Visits
12.5.8.2.3. Mental
Health-Related Appointments
12.5.8.2.4. Medical
Specialist Visits
12.5.8.2.5. Rehabilitation
12.5.8.2.6. Testing/Screening-Related
Appointments
12.5.8.2.7. Chemotherapy
12.5.8.2.8. Others
12.5.8.3. Rest
of Europe Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
12.5.8.3.1. Below
20 years
12.5.8.3.2. 20
to 60 years
12.5.8.3.3. 60+
years
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By Service
Type
12.6.3. By
Application
12.6.4. By Age
Groups
13. Asia Pacific Non-Emergency Health Transportation Market
Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Asia
Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn)
13.2. Asia
Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.2.1. Private
Pay Patient Transportation
13.2.1.1. Standard
13.2.1.2. Special
Assistance
13.2.2. Insurance
Backed Patient Transportation
13.2.2.1. Standard
13.2.2.2. Special
Assistance
13.2.3. Courier
Services
13.2.4. Transportation
Management and Optimization
13.3. Asia
Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
13.3.1. Dialysis
13.3.2. Routine
Doctor Visits
13.3.3. Mental
Health-Related Appointments
13.3.4. Medical
Specialist Visits
13.3.5. Rehabilitation
13.3.6. Testing/Screening-Related
Appointments
13.3.7. Chemotherapy
13.3.8. Others
13.4. Asia
Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
13.4.1. Below
20 years
13.4.2. 20 to
60 years
13.4.3. 60+
years
13.5. Asia
Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.1. China
13.5.1.1. China
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.5.1.1.1. Private
Pay Patient Transportation
13.5.1.1.1.1. Standard
13.5.1.1.1.2. Special
Assistance
13.5.1.1.2. Insurance
Backed Patient Transportation
13.5.1.1.2.1. Standard
13.5.1.1.2.2. Special
Assistance
13.5.1.1.3. Courier
Services
13.5.1.1.4. Transportation
Management and Optimization
13.5.1.2. China
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.1.2.1. Dialysis
13.5.1.2.2. Routine
Doctor Visits
13.5.1.2.3. Mental
Health-Related Appointments
13.5.1.2.4. Medical
Specialist Visits
13.5.1.2.5. Rehabilitation
13.5.1.2.6. Testing/Screening-Related
Appointments
13.5.1.2.7. Chemotherapy
13.5.1.2.8. Others
13.5.1.3. China
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
13.5.1.3.1. Below
20 years
13.5.1.3.2. 20
to 60 years
13.5.1.3.3. 60+
years
13.5.2. Japan
13.5.2.1. Japan
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.5.2.1.1. Private
Pay Patient Transportation
13.5.2.1.1.1. Standard
13.5.2.1.1.2. Special
Assistance
13.5.2.1.2. Insurance
Backed Patient Transportation
13.5.2.1.2.1. Standard
13.5.2.1.2.2. Special
Assistance
13.5.2.1.3. Courier
Services
13.5.2.1.4. Transportation
Management and Optimization
13.5.2.2. Japan
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.2.2.1. Dialysis
13.5.2.2.2. Routine
Doctor Visits
13.5.2.2.3. Mental
Health-Related Appointments
13.5.2.2.4. Medical
Specialist Visits
13.5.2.2.5. Rehabilitation
13.5.2.2.6. Testing/Screening-Related
Appointments
13.5.2.2.7. Chemotherapy
13.5.2.2.8. Others
13.5.2.3. Japan
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
13.5.2.3.1. Below
20 years
13.5.2.3.2. 20
to 60 years
13.5.2.3.3. 60+
years
13.5.3. India
13.5.3.1. India
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.5.3.1.1. Private
Pay Patient Transportation
13.5.3.1.1.1. Standard
13.5.3.1.1.2. Special
Assistance
13.5.3.1.2. Insurance
Backed Patient Transportation
13.5.3.1.2.1. Standard
13.5.3.1.2.2. Special
Assistance
13.5.3.1.3. Courier
Services
13.5.3.1.4. Transportation
Management and Optimization
13.5.3.2. India
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.3.2.1. Dialysis
13.5.3.2.2. Routine
Doctor Visits
13.5.3.2.3. Mental
Health-Related Appointments
13.5.3.2.4. Medical
Specialist Visits
13.5.3.2.5. Rehabilitation
13.5.3.2.6. Testing/Screening-Related
Appointments
13.5.3.2.7. Chemotherapy
13.5.3.2.8. Others
13.5.3.3. India
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
13.5.3.3.1. Below
20 years
13.5.3.3.2. 20
to 60 years
13.5.3.3.3. 60+
years
13.5.4. New
Zealand
13.5.4.1. New
Zealand Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.5.4.1.1. Private
Pay Patient Transportation
13.5.4.1.1.1. Standard
13.5.4.1.1.2. Special
Assistance
13.5.4.1.2. Insurance
Backed Patient Transportation
13.5.4.1.2.1. Standard
13.5.4.1.2.2. Special
Assistance
13.5.4.1.3. Courier
Services
13.5.4.1.4. Transportation
Management and Optimization
13.5.4.2. New
Zealand Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.4.2.1. Dialysis
13.5.4.2.2. Routine
Doctor Visits
13.5.4.2.3. Mental
Health-Related Appointments
13.5.4.2.4. Medical
Specialist Visits
13.5.4.2.5. Rehabilitation
13.5.4.2.6. Testing/Screening-Related
Appointments
13.5.4.2.7. Chemotherapy
13.5.4.2.8. Others
13.5.4.3. New
Zealand Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
13.5.4.3.1. Below
20 years
13.5.4.3.2. 20
to 60 years
13.5.4.3.3. 60+
years
13.5.5. Australia
13.5.5.1. Australia
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
13.5.5.1.1. Private
Pay Patient Transportation
13.5.5.1.1.1. Standard
13.5.5.1.1.2. Special
Assistance
13.5.5.1.2. Insurance
Backed Patient Transportation
13.5.5.1.2.1. Standard
13.5.5.1.2.2. Special
Assistance
13.5.5.1.3. Courier
Services
13.5.5.1.4. Transportation
Management and Optimization
13.5.5.2. Australia
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
13.5.5.2.1. Dialysis
13.5.5.2.2. Routine
Doctor Visits
13.5.5.2.3. Mental
Health-Related Appointments
13.5.5.2.4. Medical
Specialist Visits
13.5.5.2.5. Rehabilitation
13.5.5.2.6. Testing/Screening-Related
Appointments
13.5.5.2.7. Chemotherapy
13.5.5.2.8. Others
13.5.5.3. Australia
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
13.5.5.3.1. Below
20 years
13.5.5.3.2. 20
to 60 years
13.5.5.3.3. 60+
years
13.5.6. South
Korea
13.5.6.1. South
Korea Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.5.6.1.1. Private
Pay Patient Transportation
13.5.6.1.1.1. Standard
13.5.6.1.1.2. Special
Assistance
13.5.6.1.2. Insurance
Backed Patient Transportation
13.5.6.1.2.1. Standard
13.5.6.1.2.2. Special
Assistance
13.5.6.1.3. Courier
Services
13.5.6.1.4. Transportation
Management and Optimization
13.5.6.2. South
Korea Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.6.2.1. Dialysis
13.5.6.2.2. Routine
Doctor Visits
13.5.6.2.3. Mental
Health-Related Appointments
13.5.6.2.4. Medical
Specialist Visits
13.5.6.2.5. Rehabilitation
13.5.6.2.6. Testing/Screening-Related
Appointments
13.5.6.2.7. Chemotherapy
13.5.6.2.8. Others
13.5.6.3. South
Korea Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
13.5.6.3.1. Below
20 years
13.5.6.3.2. 20
to 60 years
13.5.6.3.3. 60+
years
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Service Type
13.5.7.1.1. Private
Pay Patient Transportation
13.5.7.1.1.1. Standard
13.5.7.1.1.2. Special
Assistance
13.5.7.1.2. Insurance
Backed Patient Transportation
13.5.7.1.2.1. Standard
13.5.7.1.2.2. Special
Assistance
13.5.7.1.3. Courier
Services
13.5.7.1.4. Transportation
Management and Optimization
13.5.7.2. Southeast
Asia Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.7.2.1. Dialysis
13.5.7.2.2. Routine
Doctor Visits
13.5.7.2.3. Mental
Health-Related Appointments
13.5.7.2.4. Medical
Specialist Visits
13.5.7.2.5. Rehabilitation
13.5.7.2.6. Testing/Screening-Related
Appointments
13.5.7.2.7. Chemotherapy
13.5.7.2.8. Others
13.5.7.3. Southeast
Asia Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Age Groups
13.5.7.3.1. Below
20 years
13.5.7.3.2. 20
to 60 years
13.5.7.3.3. 60+
years
13.5.7.4. Southeast
Asia Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
13.5.8.1.1. Private
Pay Patient Transportation
13.5.8.1.1.1. Standard
13.5.8.1.1.2. Special
Assistance
13.5.8.1.2. Insurance
Backed Patient Transportation
13.5.8.1.2.1. Standard
13.5.8.1.2.2. Special
Assistance
13.5.8.1.3. Courier
Services
13.5.8.1.4. Transportation
Management and Optimization
13.5.8.2. Rest
of Asia Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.8.2.1. Dialysis
13.5.8.2.2. Routine
Doctor Visits
13.5.8.2.3. Mental
Health-Related Appointments
13.5.8.2.4. Medical
Specialist Visits
13.5.8.2.5. Rehabilitation
13.5.8.2.6. Testing/Screening-Related
Appointments
13.5.8.2.7. Chemotherapy
13.5.8.2.8. Others
13.5.8.3. Rest
of Asia Pacific Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
13.5.8.3.1. Below
20 years
13.5.8.3.2. 20
to 60 years
13.5.8.3.3. 60+
years
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Service Type
13.6.3. By
Application
13.6.4. By Age
Groups
14. Middle East and Africa Non-Emergency Health Transportation
Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa Non-Emergency Health Transportation Market Revenue (US$ Mn)
14.2. Middle
East and Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.2.1. Private
Pay Patient Transportation
14.2.1.1. Standard
14.2.1.2. Special
Assistance
14.2.2. Insurance
Backed Patient Transportation
14.2.2.1. Standard
14.2.2.2. Special
Assistance
14.2.3. Courier
Services
14.2.4. Transportation
Management and Optimization
14.3. Middle
East and Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
14.3.1. Dialysis
14.3.2. Routine
Doctor Visits
14.3.3. Mental
Health-Related Appointments
14.3.4. Medical
Specialist Visits
14.3.5. Rehabilitation
14.3.6. Testing/Screening-Related
Appointments
14.3.7. Chemotherapy
14.3.8. Others
14.4. Middle
East and Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
14.4.1. Below
20 years
14.4.2. 20 to
60 years
14.4.3. 60+
years
14.5. Middle
East and Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.5.1.1.1. Private
Pay Patient Transportation
14.5.1.1.1.1. Standard
14.5.1.1.1.2. Special
Assistance
14.5.1.1.2. Insurance
Backed Patient Transportation
14.5.1.1.2.1. Standard
14.5.1.1.2.2. Special
Assistance
14.5.1.1.3. Courier
Services
14.5.1.1.4. Transportation
Management and Optimization
14.5.1.2. Saudi
Arabia Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.1.2.1. Dialysis
14.5.1.2.2. Routine
Doctor Visits
14.5.1.2.3. Mental
Health-Related Appointments
14.5.1.2.4. Medical
Specialist Visits
14.5.1.2.5. Rehabilitation
14.5.1.2.6. Testing/Screening-Related
Appointments
14.5.1.2.7. Chemotherapy
14.5.1.2.8. Others
14.5.1.3. Saudi
Arabia Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
14.5.1.3.1. Below
20 years
14.5.1.3.2. 20
to 60 years
14.5.1.3.3. 60+
years
14.5.2. UAE
14.5.2.1. UAE
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
14.5.2.1.1. Private
Pay Patient Transportation
14.5.2.1.1.1. Standard
14.5.2.1.1.2. Special
Assistance
14.5.2.1.2. Insurance
Backed Patient Transportation
14.5.2.1.2.1. Standard
14.5.2.1.2.2. Special
Assistance
14.5.2.1.3. Courier
Services
14.5.2.1.4. Transportation
Management and Optimization
14.5.2.2. UAE
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.2.2.1. Dialysis
14.5.2.2.2. Routine
Doctor Visits
14.5.2.2.3. Mental
Health-Related Appointments
14.5.2.2.4. Medical
Specialist Visits
14.5.2.2.5. Rehabilitation
14.5.2.2.6. Testing/Screening-Related
Appointments
14.5.2.2.7. Chemotherapy
14.5.2.2.8. Others
14.5.2.3. UAE
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
14.5.2.3.1. Below
20 years
14.5.2.3.2. 20
to 60 years
14.5.2.3.3. 60+
years
14.5.3. Egypt
14.5.3.1. Egypt
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
14.5.3.1.1. Private
Pay Patient Transportation
14.5.3.1.1.1. Standard
14.5.3.1.1.2. Special
Assistance
14.5.3.1.2. Insurance
Backed Patient Transportation
14.5.3.1.2.1. Standard
14.5.3.1.2.2. Special
Assistance
14.5.3.1.3. Courier
Services
14.5.3.1.4. Transportation
Management and Optimization
14.5.3.2. Egypt
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.3.2.1. Dialysis
14.5.3.2.2. Routine
Doctor Visits
14.5.3.2.3. Mental
Health-Related Appointments
14.5.3.2.4. Medical
Specialist Visits
14.5.3.2.5. Rehabilitation
14.5.3.2.6. Testing/Screening-Related
Appointments
14.5.3.2.7. Chemotherapy
14.5.3.2.8. Others
14.5.3.3. Egypt
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
14.5.3.3.1. Below
20 years
14.5.3.3.2. 20
to 60 years
14.5.3.3.3. 60+
years
14.5.4. Kuwait
14.5.4.1. Kuwait
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
14.5.4.1.1. Private
Pay Patient Transportation
14.5.4.1.1.1. Standard
14.5.4.1.1.2. Special
Assistance
14.5.4.1.2. Insurance
Backed Patient Transportation
14.5.4.1.2.1. Standard
14.5.4.1.2.2. Special
Assistance
14.5.4.1.3. Courier
Services
14.5.4.1.4. Transportation
Management and Optimization
14.5.4.2. Kuwait
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.4.2.1. Dialysis
14.5.4.2.2. Routine
Doctor Visits
14.5.4.2.3. Mental
Health-Related Appointments
14.5.4.2.4. Medical
Specialist Visits
14.5.4.2.5. Rehabilitation
14.5.4.2.6. Testing/Screening-Related
Appointments
14.5.4.2.7. Chemotherapy
14.5.4.2.8. Others
14.5.4.3. Kuwait
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
14.5.4.3.1. Below
20 years
14.5.4.3.2. 20
to 60 years
14.5.4.3.3. 60+
years
14.5.5. South
Africa
14.5.5.1. South
Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.5.5.1.1. Private
Pay Patient Transportation
14.5.5.1.1.1. Standard
14.5.5.1.1.2. Special
Assistance
14.5.5.1.2. Insurance
Backed Patient Transportation
14.5.5.1.2.1. Standard
14.5.5.1.2.2. Special
Assistance
14.5.5.1.3. Courier
Services
14.5.5.1.4. Transportation
Management and Optimization
14.5.5.2. South
Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.5.2.1. Dialysis
14.5.5.2.2. Routine
Doctor Visits
14.5.5.2.3. Mental
Health-Related Appointments
14.5.5.2.4. Medical
Specialist Visits
14.5.5.2.5. Rehabilitation
14.5.5.2.6. Testing/Screening-Related
Appointments
14.5.5.2.7. Chemotherapy
14.5.5.2.8. Others
14.5.5.3. South
Africa Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
14.5.5.3.1. Below
20 years
14.5.5.3.2. 20
to 60 years
14.5.5.3.3. 60+
years
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Non-Emergency Health Transportation Market Revenue
(US$ Mn) and Forecasts, By Service Type
14.5.6.1.1. Private
Pay Patient Transportation
14.5.6.1.1.1. Standard
14.5.6.1.1.2. Special
Assistance
14.5.6.1.2. Insurance
Backed Patient Transportation
14.5.6.1.2.1. Standard
14.5.6.1.2.2. Special
Assistance
14.5.6.1.3. Courier
Services
14.5.6.1.4. Transportation
Management and Optimization
14.5.6.2. Rest
of Middle East & Africa Non-Emergency Health Transportation Market Revenue
(US$ Mn) and Forecasts, By Application
14.5.6.2.1. Dialysis
14.5.6.2.2. Routine
Doctor Visits
14.5.6.2.3. Mental
Health-Related Appointments
14.5.6.2.4. Medical
Specialist Visits
14.5.6.2.5. Rehabilitation
14.5.6.2.6. Testing/Screening-Related
Appointments
14.5.6.2.7. Chemotherapy
14.5.6.2.8. Others
14.5.6.3. Rest
of Middle East & Africa Non-Emergency Health Transportation Market Revenue
(US$ Mn) and Forecasts, By Age Groups
14.5.6.3.1. Below
20 years
14.5.6.3.2. 20
to 60 years
14.5.6.3.3. 60+
years
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Service Type
14.6.3. By
Application
14.6.4. By Age
Groups
15. Latin America Non-Emergency Health Transportation Market
Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Latin
America Non-Emergency Health Transportation Market Revenue (US$ Mn)
15.2. Latin
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Service Type
15.2.1. Private
Pay Patient Transportation
15.2.1.1. Standard
15.2.1.2. Special
Assistance
15.2.2. Insurance
Backed Patient Transportation
15.2.2.1. Standard
15.2.2.2. Special
Assistance
15.2.3. Courier
Services
15.2.4. Transportation
Management and Optimization
15.3. Latin
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Application
15.3.1. Dialysis
15.3.2. Routine
Doctor Visits
15.3.3. Mental
Health-Related Appointments
15.3.4. Medical
Specialist Visits
15.3.5. Rehabilitation
15.3.6. Testing/Screening-Related
Appointments
15.3.7. Chemotherapy
15.3.8. Others
15.4. Latin
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Age Groups
15.4.1. Below
20 years
15.4.2. 20 to
60 years
15.4.3. 60+
years
15.5. Latin
America Non-Emergency Health Transportation Market Revenue (US$ Mn) and
Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
15.5.1.1.1. Private
Pay Patient Transportation
15.5.1.1.1.1. Standard
15.5.1.1.1.2. Special
Assistance
15.5.1.1.2. Insurance
Backed Patient Transportation
15.5.1.1.2.1. Standard
15.5.1.1.2.2. Special
Assistance
15.5.1.1.3. Courier
Services
15.5.1.1.4. Transportation
Management and Optimization
15.5.1.2. Brazil
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.1.2.1. Dialysis
15.5.1.2.2. Routine
Doctor Visits
15.5.1.2.3. Mental
Health-Related Appointments
15.5.1.2.4. Medical
Specialist Visits
15.5.1.2.5. Rehabilitation
15.5.1.2.6. Testing/Screening-Related
Appointments
15.5.1.2.7. Chemotherapy
15.5.1.2.8. Others
15.5.1.3. Brazil
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
15.5.1.3.1. Below
20 years
15.5.1.3.2. 20
to 60 years
15.5.1.3.3. 60+
years
15.5.2. Argentina
15.5.2.1. Argentina
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Service Type
15.5.2.1.1. Private
Pay Patient Transportation
15.5.2.1.1.1. Standard
15.5.2.1.1.2. Special
Assistance
15.5.2.1.2. Insurance
Backed Patient Transportation
15.5.2.1.2.1. Standard
15.5.2.1.2.2. Special
Assistance
15.5.2.1.3. Courier
Services
15.5.2.1.4. Transportation
Management and Optimization
15.5.2.2. Argentina
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.2.2.1. Dialysis
15.5.2.2.2. Routine
Doctor Visits
15.5.2.2.3. Mental
Health-Related Appointments
15.5.2.2.4. Medical
Specialist Visits
15.5.2.2.5. Rehabilitation
15.5.2.2.6. Testing/Screening-Related
Appointments
15.5.2.2.7. Chemotherapy
15.5.2.2.8. Others
15.5.2.3. Argentina
Non-Emergency Health Transportation Market Revenue (US$ Mn) and Forecasts, By
Age Groups
15.5.2.3.1. Below
20 years
15.5.2.3.2. 20
to 60 years
15.5.2.3.3. 60+
years
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Service Type
15.5.3.1.1. Private
Pay Patient Transportation
15.5.3.1.1.1. Standard
15.5.3.1.1.2. Special
Assistance
15.5.3.1.2. Insurance
Backed Patient Transportation
15.5.3.1.2.1. Standard
15.5.3.1.2.2. Special
Assistance
15.5.3.1.3. Courier
Services
15.5.3.1.4. Transportation
Management and Optimization
15.5.3.2. Rest
of Latin America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Application
15.5.3.2.1. Dialysis
15.5.3.2.2. Routine
Doctor Visits
15.5.3.2.3. Mental
Health-Related Appointments
15.5.3.2.4. Medical
Specialist Visits
15.5.3.2.5. Rehabilitation
15.5.3.2.6. Testing/Screening-Related
Appointments
15.5.3.2.7. Chemotherapy
15.5.3.2.8. Others
15.5.3.3. Rest
of Latin America Non-Emergency Health Transportation Market Revenue (US$ Mn)
and Forecasts, By Age Groups
15.5.3.3.1. Below
20 years
15.5.3.3.2. 20
to 60 years
15.5.3.3.3. 60+
years
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Service Type
15.6.3. By
Application
15.6.4. By Age
Groups
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2018
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. ABC
Non-Emergency Medical Transportation, LLC
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Acadian
Ambulance Service
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Access2Care
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. American
Logistics
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Care
Quality Commission
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Express
Medical Transporters
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. IU Group
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. London
Medical Transportation Systems
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Lyft,
Inc.
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. One-Stop
MedEx
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. ProHealth
Care
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. Providence
Service Corporation
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. Uber Technologies Inc.
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business
Strategies
17.14. Other
Market Participants
18. Key Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
